You are here:

  1. NICE
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Spinal conditions

Onasemnogene abeparvovec for treating spinal muscular atrophy

  • Highly specialised technologies guidance
  • Reference number: HST15
  • Published:  07 July 2021
  • Last updated:  19 April 2023
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Education
  2. Guidance into practice

Tools and resources

Tools to help you put the guidance into practice.

Education

  • Managed access agreement (PDF 388 KB)

    Published:
    07 July 2021

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance